Tag Archives: R21/Matrix-M malaria vaccine

Ghana approves Oxford-developed malaria vaccine for use in children

(IN BRIEF) The Food and Drugs Authority of Ghana has granted full national licensure for the R21/Matrix-M malaria vaccine developed by the University of Oxford and manufactured by the Serum Institute of India using Novavax’s adjuvant technology. This marks the … Read the full press release